NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Mukesh Ambani
    WhatsApp
    Reliance Jio
    OPPO
    Vivo
    Sensex
    Bitcoin
    NewsBytes
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout


    India Business World Politics Sports Technology Entertainment Auto Lifestyle Inspirational Career Bengaluru Delhi Mumbai Visual Stories Find Cricket Statistics Phones Reviews Fitness Bands Reviews Speakers Reviews

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
     
    Home / News / Business News / Largest possible Chinese investment in India stalled by government
    Business

    Largest possible Chinese investment in India stalled by government

    Largest possible Chinese investment in India stalled by government
    Written by Gogona Saikia
    Aug 01, 2017, 01:33 pm 2 min read
    Largest possible Chinese investment in India stalled by government

    Amid the India-China standoff at Doklam, a central panel has stalled a bid by a Chinese pharma group for majority stake in a Hyderabad-based brand. The FIPB had cleared the $1.3bn bid by Shanghai Fosun Pharmaceutical Group (SFP) for 86% stake in Gland Pharma, but it now needs clearance from the CCEA. Apparently there were "genuine concerns" over proprietary technology developed by Gland Pharma.

    India nod to pharma FDI opened doors for Chinese billionaire

    According to reports, Gland Pharma leads in injectibles, an area where Chinese firms lag behind Indian ones. The company claims to be a global leader in Glycosaminoglycans range of molecules. After India opened doors for 74% FDI in pharma through the automatic route, Chinese billionaire Guo Guangchang made a billion-dollar deal for Gland Pharma. It was potentially the largest Chinese acquisition in India.

    Setback comes as a surprise for Gland Pharma

    Currently, Gland Pharma promoter Ravi Penmetsa's family along with KKR, a US private equity firm, own over 95% stake in the company. When they announced a sale, several parties including US-based Baxter and buyout investor Advent International expressed interest. But according to Gland Pharma, "We have not heard anything about (a rejection from the government)." "We didn't expect any hurdles," a senior executive said.

    Share this timeline
    Facebook
    Whatsapp
    Twitter
    Linkedin
    India
    Kolkata Knight Riders (KKR)
    Indian Government

    India

    US: Flyers will now face stricter checks for electronics Qatar Airways
    WhatsApp plans to launch another app, will start monetization iOS
    Boeing pegs India's demand at 2,100 aircraft, over 20 years Boeing
    Voto, Infinix, Comio ready to make smartphone debut in India Smartphones

    Kolkata Knight Riders (KKR)

    What can happen to SRK in the FEMA violation case? Indian Premier League (IPL)
    'Mary Kom' Priyanka Chopra to own Super Boxing League franchise? Bollywood
    IPL 2017- A recap of amazing feats Indian Premier League (IPL)
    IPL- Mumbai defeat Kolkata; to play Pune in the finals Indian Premier League (IPL)

    Indian Government

    Major embarrassment for govt: 30 NDA MPs skip Parliament Parliament Monsoon Session
    Project Insight: Your Facebook/Instagram post can soon detect tax frauds Facebook
    Securing Amarnath Yatra: Government issues food advisory to CRPF Amarnath Yatra
    Unaccounted income of Rs. 71,941 crore found: Govt. tells SC Supreme Court Of India

    Love Business News?

    Subscribe to stay updated.

    Business Thumbnail
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2023